Crunch Time For 18 Products Seeking EU Approval, "No" Stays In Place for Radius
Two drugs filed via the rarely-used used EU pediatric-use marketing authorization pathway are among 18 products up for an opinion from the European Medicines Agency this week on whether they should be approved. Also, Radius Health has already said its appeal has failed. What news will there be on Portola's appeal?